Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.

Oxford Nanopore, the UK-based DNA sequencing technology spinout of University of Oxford, has secured software producer Oracle as a cornerstone investor for its initial public offering on the London Stock Exchange. Oracle will invest £150m ($205m), halfway to Oxford Nanopore’s target of $410m. The two companies have also entered into a partnership to explore potential…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.